A new indication for statins to prevent venous thromboembolism? Not yet

Journal of Thrombosis and Haemostasis

Volumn 7, Issue 4, 2009, Pages 511-513

  Cushman, Mary ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ATHEROSCLEROSIS; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG INDICATION; ENVIRONMENTAL FACTOR; HEREDITY; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; SAMPLE SIZE; SELF REPORT; SYSTEMATIC ERROR; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

AGE FACTORS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; OBESITY; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 63049129940     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03282.x     Document Type: Note

References (13)

1. Undas A, Brummel-Ziedins KE, Mann KG. Statins and blood coagulation. Arterioscler Thromb Vasc Biol 2005; 25: 287-94.
2. Ramcharan AS, van Stralen KJ, Mantel-Teeuwisse AK, Rosendaal FR, Doggen CJM. HMG-CoA reductase inhibitors are associated with a reduced risk of venous thrombosis. J Thromb Haemost 2009; 7: 514-20.
3. Sørensen HT, Horvath-Puho E, Søgaard KK, Christensen S, Johnson SP, Thomsen RW, Prandoni P, Baron JA. Arterial cardiovascular events, statins, low dose aspirin and subsequent risk of venous thromboembolism: A population-based case-control study. J Thromb Haemost 2009; 7: 521-8.
4. Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, Vittinghoff E, Hulley S, for the Heart Estrogen/progestin Replacement Study Research Group. Postmenopausal hormone therapy increases risk for venous thromboembolic disease: The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 2000; 132: 689-96.
5. Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161: 1405-10.
6. Yang CC, Jick SS, Jick H. Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 2002; 53: 101-5.
7. Doggen CJM, Lemaitre RN, Smith NL, Heckbert SR, Psaty BM. HMG. CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost 2003; 2:700-1.
8. Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, Mottier D. Statins but not fibrates are associated with a reduced risk of venous thromboembolism: A hospital-based case-control study. Fundam Clin Pharmacol 2004; 18: 477-82.
9. Abdollahi M, Cushman M, Rosendaal FR. Obesity: Risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost 2003; 89: 493-8.
10. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW. Cardiovascular risk factors and venous thromboembolism: A meta-analysis. Circulation 2008; 117: 93-102.
11. Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348:1425-34.
12. Kearon C, Ginsberg JS, Kovacs MJ, Anderson DR, Wells P, Julian JA, MacKinnon B, Weitz JI, Crowther MA, Dolan S, Turpie AG, Geerts W, Solymoss S, van Nguyen P, Demers C, Kahn SR, Kassis J, Rodger M, Hambleton J, Gent M. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349:631-9.
13. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-207.